Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00139217 · ClinicalTrials.gov registry record · NA

NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
400
Enrollment target

NCT00139217: Completed NA study, sponsored by Emory University.

NCT00139217 is a NA study that has completed, run by Emory University. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00139217, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target

Study Summary

The primary objective of the trial is to determine the feasibility and clinical safety and efficacy of non-invasive inhaled nitric oxide in infants with PPHN without significant pulmonary +-parenchymal disease who would normally receive inhaled nitric oxide only after placement of a tracheal tube and the institution of mechanical ventilation.

Interventions

  • DRUG iNO
  • PROCEDURE Non-invasive nitric oxide

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2005-08
Est. Completion 2007-09
Phase NA
Emory University

1,208 total trials

What the finished NCT00139217 record still lists

NCT00139217 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).

The record links to 0 conditions, and to 2 interventions - of which iNO is the first listed.

NCT00139217 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00139217 about?

NCT00139217 is a clinical study titled "NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn". The primary objective of the trial is to determine the feasibility and clinical safety and efficacy of non-invasive inhaled nitric oxide in infants with PPHN without significant pulmonary +-parenchymal disease who would normally receive inhaled nitric oxide only after placement of a tracheal tube an...

What is the current status of trial NCT00139217?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2005-08. Estimated completion is 2007-09.

What interventions are being tested in trial NCT00139217?

The interventions under investigation include: iNO (DRUG), Non-invasive nitric oxide (PROCEDURE).

Who is sponsoring clinical trial NCT00139217?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00139217's enrollment target sits among peer trials

400 246th of 2000 higher than 1,734 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00139217, the US trial registry maintained by the National Library of Medicine. NCT00139217 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.